[1]CurrentPatentAssignee:VALIANTCO.,LTD.-CN107382925,2017,ALocationinpatent:Paragraph0065-0067;0095-0097;0125-0127
[2]Huang,Wenbo;Xu,Jing;Liu,Changhui;Chen,Zhiyan;Gu,Yanlong[JournalofOrganicChemistry,2019,vol.84,#5,p.2941-2950]
[3]Ha;Stieger;Grassi;Altorfer;Follath[EuropeanJournalofClinicalPharmacology,2000,vol.55,#11-12,p.807-814]
[4]CurrentPatentAssignee:PFIZERINC-US6103708,2000,A
[5]CurrentPatentAssignee:ZHEJIANGPOLYPHARMACEUTICAL;HAINANPOLYPHARMACEUTICAL-CN109988131,2019,ALocationinpatent:Paragraph0016
[1]Patent:US5266711,1993,A
[2]BioorganicandMedicinalChemistryLetters,2021,vol.46
[3]Patent:CN109053652,2018,A.Locationinpatent:Paragraph0019;0055;0061;0064;0070;0079;0081
[4]JournalofOrganicChemistry,2019,vol.84,p.2941-2950
[5]Patent:WO2012/48058,2012,A2.Locationinpatent:Page/Pagecolumn43
[6]Patent:CN106946822,2017,A.Locationinpatent:Paragraph0028;0034;0040;0046-0047;0052
[7]Patent:CN109988131,2019,A.Locationinpatent:Paragraph0015
[1]Patent:US4565828,1986,A
[1]Snead,AaronN.;Miyakawa,Motonori;Tan,EdwinS.;Scanlan,ThomasS.[BioorganicandMedicinalChemistryLetters,2008,vol.18,#22,p.5920-5922]
[1]Patel,HitendraM.[JournaloftheSerbianChemicalSociety,2012,vol.77,#11,p.1551-1560]
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101